
Hypr-Spectral Pct For Preclinical ImagingAward last edited on: 10/9/08
Sponsored Program
SBIRAwarding Agency
NIH : NCRRTotal Award Amount
$193,879Award Phase
1Solicitation Topic Code
-----Principal Investigator
Robert A KrugerCompany Information
Phase I
Contract Number: 1R43RR025872-01Start Date: 00/00/00 Completed: 00/00/00
Phase I year
2008Phase I Amount
$193,879Public Health Relevance:
Scientists at pharmaceutical companies and academic institutions routinely employ preclinical imaging of small animals, especially mice, to study disease progression and monitor response to therapies. We propose to develop a novel, photoacoustic-imaging device that would allow researchers to interrogate the molecular structure of disease and assess response to therapy in a preclinical setting using near infrared radiation. This device would allow researchers to quantify hemoglobin concentration, blood flow, tissue oxygenation, and the accumulation of molecular probes in targeted tissues in small animals with excellent 3-D spatial and temporal resolution.
Public Health Relevance:
This Public Health Relevance is not available.
Thesaurus Terms:
There Are No Thesaurus Terms On File For This Project.
Phase II
Contract Number: ----------Start Date: 00/00/00 Completed: 00/00/00